LLY

733.87

+2.71%↑

JNJ

149.53

+2.14%↑

UNH

273.23

-11.3%↓

ABBV

181.65

+2.56%↑

NVO

66.05

+2.69%↑

LLY

733.87

+2.71%↑

JNJ

149.53

+2.14%↑

UNH

273.23

-11.3%↓

ABBV

181.65

+2.56%↑

NVO

66.05

+2.69%↑

LLY

733.87

+2.71%↑

JNJ

149.53

+2.14%↑

UNH

273.23

-11.3%↓

ABBV

181.65

+2.56%↑

NVO

66.05

+2.69%↑

LLY

733.87

+2.71%↑

JNJ

149.53

+2.14%↑

UNH

273.23

-11.3%↓

ABBV

181.65

+2.56%↑

NVO

66.05

+2.69%↑

LLY

733.87

+2.71%↑

JNJ

149.53

+2.14%↑

UNH

273.23

-11.3%↓

ABBV

181.65

+2.56%↑

NVO

66.05

+2.69%↑

Search

Cassava Sciences Inc

Cerrado

SectorSanidad

2.05 9.04

Resumen

Variación precio

24h

Actual

Mínimo

1.82

Máximo

2.05

Métricas clave

By Trading Economics

Ingresos

4.2M

-23M

BPA

-0.57

Empleados

30

EBITDA

1.4M

-30M

Recomendaciones

By TipRanks

Recomendaciones

Vender

Estimación a 12 Meses

+6.38% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

11M

88M

Apertura anterior

-6.99

Cierre anterior

2.05

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

173 / 382 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Cassava Sciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 sept 2024, 10:48 UTC

Principales Movimientos del Mercado

Cassava Sciences Shares Lower Premarket on $40 Million Penalty to Settle Doctored Data Claims

28 jun 2024, 20:15 UTC

Principales Movimientos del Mercado

Cassava Sciences' Shares Down 46% After Adviser Is Indicted

27 sept 2024, 18:36 UTC

Ganancias

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More -- Barrons.com

27 sept 2024, 09:15 UTC

Acciones populares

Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco -- WSJ

Comparación entre iguales

Cambio de precio

Cassava Sciences Inc previsión

Precio Objetivo

By TipRanks

6.38% repunte

Estimación a 12 Meses

Media 2 USD  6.38%

Máximo 2 USD

Mínimo 2 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cassava Sciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

2 ratings

0

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

1.56 / 1.7Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

173 / 382 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.